APO Research
Talk to an analyst

APO RESEARCH · REPORT

Duck Medicine and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Duck Medicine and Vaccines Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchDuck Medicine and Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Duck Medicine and Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Duck Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duck Medicine and Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Duck Medicine and Vaccines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Duck Medicine and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Duck Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Duck Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Duck Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Duck Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Duck Medicine and Vaccines include Zoetis, Yebio, Vaksindo, Ringpu Biology, QYH Biotech, Merial, Merck Animal Health, Harbin Veterinary Research Institute and FATRO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Duck Medicine and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Duck Medicine and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Duck Medicine and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Duck Medicine and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Duck Medicine and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Duck Medicine and Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Duck Medicine and Vaccines Segment by Company

Zoetis

Yebio

Vaksindo

Ringpu Biology

QYH Biotech

Merial

Merck Animal Health

Harbin Veterinary Research Institute

FATRO

Elanco (Lohmann)

DHN

ChengDu Tecbond

CEVA

CAVAC

Duck Medicine and Vaccines Segment by Type

Medicine

Vaccines

Duck Medicine and Vaccines Segment by Application

Farm

Government

Duck Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duck Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Duck Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Duck Medicine and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Duck Medicine and Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Duck Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medicine Major Player Table 3. Vaccines Major Player Table 4. Global Duck Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Farm Major Player Table 6. Government Major Player Table 7. Duck Medicine and Vaccines Industry Trends Table 8. Duck Medicine and Vaccines Industry Drivers Table 9. Duck Medicine and Vaccines Industry Opportunities and Challenges Table 10. Duck Medicine and Vaccines Industry Restraints Table 11. Global Duck Medicine and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Duck Medicine and Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Duck Medicine and Vaccines Market Share by Region (2021-2026) Table 14. Global Duck Medicine and Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Duck Medicine and Vaccines Market Share by Region (2027-2032) Table 16. Global Duck Medicine and Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Duck Medicine and Vaccines Revenue Market Share by Players (2021-2026) Table 18. Global Duck Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Duck Medicine and Vaccines Key Players Headquarters & Area Served Table 20. Global Duck Medicine and Vaccines Players, Product Type & Application Table 21. Global Duck Medicine and Vaccines Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Duck Medicine and Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Duck Medicine and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Duck Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Duck Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Duck Medicine and Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Duck Medicine and Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global Duck Medicine and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Duck Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Duck Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Duck Medicine and Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global Duck Medicine and Vaccines Revenue Market Share by Application (2027-2032) Table 34. Zoetis Company Information Table 35. Zoetis Business Overview Table 36. Zoetis Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Zoetis Duck Medicine and Vaccines Product Portfolio Table 38. Zoetis Recent Development Table 39. Yebio Company Information Table 40. Yebio Business Overview Table 41. Yebio Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Yebio Duck Medicine and Vaccines Product Portfolio Table 43. Yebio Recent Development Table 44. Vaksindo Company Information Table 45. Vaksindo Business Overview Table 46. Vaksindo Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Vaksindo Duck Medicine and Vaccines Product Portfolio Table 48. Vaksindo Recent Development Table 49. Ringpu Biology Company Information Table 50. Ringpu Biology Business Overview Table 51. Ringpu Biology Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Ringpu Biology Duck Medicine and Vaccines Product Portfolio Table 53. Ringpu Biology Recent Development Table 54. QYH Biotech Company Information Table 55. QYH Biotech Business Overview Table 56. QYH Biotech Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. QYH Biotech Duck Medicine and Vaccines Product Portfolio Table 58. QYH Biotech Recent Development Table 59. Merial Company Information Table 60. Merial Business Overview Table 61. Merial Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Merial Duck Medicine and Vaccines Product Portfolio Table 63. Merial Recent Development Table 64. Merck Animal Health Company Information Table 65. Merck Animal Health Business Overview Table 66. Merck Animal Health Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Merck Animal Health Duck Medicine and Vaccines Product Portfolio Table 68. Merck Animal Health Recent Development Table 69. Harbin Veterinary Research Institute Company Information Table 70. Harbin Veterinary Research Institute Business Overview Table 71. Harbin Veterinary Research Institute Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Harbin Veterinary Research Institute Duck Medicine and Vaccines Product Portfolio Table 73. Harbin Veterinary Research Institute Recent Development Table 74. FATRO Company Information Table 75. FATRO Business Overview Table 76. FATRO Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. FATRO Duck Medicine and Vaccines Product Portfolio Table 78. FATRO Recent Development Table 79. Elanco (Lohmann) Company Information Table 80. Elanco (Lohmann) Business Overview Table 81. Elanco (Lohmann) Duck Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Elanco (Lohmann) Duck Medicine and Vaccines Product Portfolio Table 83. Elanco (Lohmann) Recent Development Table 84. DHN Company Information Table 85. DHN Business Overview Table 86. DHN Duck Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. DHN Duck Medicine and Vaccines Product Portfolio Table 88. DHN Recent Development Table 89. ChengDu Tecbond Company Information Table 90. ChengDu Tecbond Business Overview Table 91. ChengDu Tecbond Duck Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. ChengDu Tecbond Duck Medicine and Vaccines Product Portfolio Table 93. ChengDu Tecbond Recent Development Table 94. CEVA Company Information Table 95. CEVA Business Overview Table 96. CEVA Duck Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. CEVA Duck Medicine and Vaccines Product Portfolio Table 98. CEVA Recent Development Table 99. CAVAC Company Information Table 100. CAVAC Business Overview Table 101. CAVAC Duck Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. CAVAC Duck Medicine and Vaccines Product Portfolio Table 103. CAVAC Recent Development Table 104. North America Duck Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Duck Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Duck Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 107. North America Duck Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 108. North America Duck Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Duck Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 110. North America Duck Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 111. Europe Duck Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Duck Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Duck Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Duck Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Duck Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Duck Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 117. Europe Duck Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 118. China Duck Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 119. China Duck Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 120. China Duck Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 121. China Duck Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Duck Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 123. Asia Duck Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 124. Asia Duck Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 125. Asia Duck Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Duck Medicine and Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia Duck Medicine and Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 128. Asia Duck Medicine and Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 129. SAMEA Duck Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 130. SAMEA Duck Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 131. SAMEA Duck Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 132. SAMEA Duck Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 133. SAMEA Duck Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. SAMEA Duck Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 135. SAMEA Duck Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Duck Medicine and Vaccines Image Figure 2. Global Duck Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Duck Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicine Image Figure 5. Vaccines Image Figure 6. Global Duck Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Duck Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Farm Image Figure 9. Government Image Figure 10. Global Duck Medicine and Vaccines Market Size (US$ Million) & (2021-2032) Figure 11. Global Duck Medicine and Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Duck Medicine and Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Duck Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Duck Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Duck Medicine and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Duck Medicine and Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Global Duck Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Duck Medicine and Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Duck Medicine and Vaccines Revenue Market Share by Application (2021-2032) Figure 21. North America Duck Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Duck Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 23. North America Duck Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 24. North America Duck Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 25. United States Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Duck Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Duck Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 30. Europe Duck Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 31. Europe Duck Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 32. Germany Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Duck Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Duck Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 42. China Duck Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 43. Asia Duck Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Duck Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 45. Asia Duck Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 46. Asia Duck Medicine and Vaccines Revenue Share by Region (2021-2032) Figure 47. Japan Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Duck Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Duck Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 55. SAMEA Duck Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 56. SAMEA Duck Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 57. Brazil Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Duck Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Farm
  • Government
Companies covered
  • Zoetis
  • Yebio
  • Vaksindo
  • Ringpu Biology
  • QYH Biotech
  • Merial
  • Merck Animal Health
  • Harbin Veterinary Research Institute
  • FATRO
  • Elanco (Lohmann)
  • DHN
  • ChengDu Tecbond
  • CEVA
  • CAVAC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Duck Medicine and Vaccines Market by Type
  3. 1.2.1 Global Duck Medicine and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medicine
  5. 1.2.3 Vaccines
  6. 1.3 Duck Medicine and Vaccines Market by Application
  7. 1.3.1 Global Duck Medicine and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Farm
  9. 1.3.3 Government
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Duck Medicine and Vaccines Market Dynamics
  1. 2.1 Duck Medicine and Vaccines Industry Trends
  2. 2.2 Duck Medicine and Vaccines Industry Drivers
  3. 2.3 Duck Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Duck Medicine and Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Duck Medicine and Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Duck Medicine and Vaccines Growth Trends by Region
  3. 3.2.1 Global Duck Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Duck Medicine and Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Duck Medicine and Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Duck Medicine and Vaccines Revenue by Players
  2. 4.1.1 Global Duck Medicine and Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Duck Medicine and Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Duck Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Duck Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Duck Medicine and Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Duck Medicine and Vaccines Players, Product Type & Application
  8. 4.5 Global Duck Medicine and Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Duck Medicine and Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Duck Medicine and Vaccines Tier 1, Tier 2, and Tier 3
5 Duck Medicine and Vaccines Market Size by Type
  1. 5.1 Global Duck Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Duck Medicine and Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Duck Medicine and Vaccines Revenue Market Share by Type (2021-2032)
6 Duck Medicine and Vaccines Market Size by Application
  1. 6.1 Global Duck Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Duck Medicine and Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Duck Medicine and Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Duck Medicine and Vaccines Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Yebio
  8. 7.2.1 Yebio Company Information
  9. 7.2.2 Yebio Business Overview
  10. 7.2.3 Yebio Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Yebio Duck Medicine and Vaccines Product Portfolio
  12. 7.2.5 Yebio Recent Developments
  13. 7.3 Vaksindo
  14. 7.3.1 Vaksindo Company Information
  15. 7.3.2 Vaksindo Business Overview
  16. 7.3.3 Vaksindo Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Vaksindo Duck Medicine and Vaccines Product Portfolio
  18. 7.3.5 Vaksindo Recent Developments
  19. 7.4 Ringpu Biology
  20. 7.4.1 Ringpu Biology Company Information
  21. 7.4.2 Ringpu Biology Business Overview
  22. 7.4.3 Ringpu Biology Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ringpu Biology Duck Medicine and Vaccines Product Portfolio
  24. 7.4.5 Ringpu Biology Recent Developments
  25. 7.5 QYH Biotech
  26. 7.5.1 QYH Biotech Company Information
  27. 7.5.2 QYH Biotech Business Overview
  28. 7.5.3 QYH Biotech Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 QYH Biotech Duck Medicine and Vaccines Product Portfolio
  30. 7.5.5 QYH Biotech Recent Developments
  31. 7.6 Merial
  32. 7.6.1 Merial Company Information
  33. 7.6.2 Merial Business Overview
  34. 7.6.3 Merial Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merial Duck Medicine and Vaccines Product Portfolio
  36. 7.6.5 Merial Recent Developments
  37. 7.7 Merck Animal Health
  38. 7.7.1 Merck Animal Health Company Information
  39. 7.7.2 Merck Animal Health Business Overview
  40. 7.7.3 Merck Animal Health Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merck Animal Health Duck Medicine and Vaccines Product Portfolio
  42. 7.7.5 Merck Animal Health Recent Developments
  43. 7.8 Harbin Veterinary Research Institute
  44. 7.8.1 Harbin Veterinary Research Institute Company Information
  45. 7.8.2 Harbin Veterinary Research Institute Business Overview
  46. 7.8.3 Harbin Veterinary Research Institute Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Harbin Veterinary Research Institute Duck Medicine and Vaccines Product Portfolio
  48. 7.8.5 Harbin Veterinary Research Institute Recent Developments
  49. 7.9 FATRO
  50. 7.9.1 FATRO Company Information
  51. 7.9.2 FATRO Business Overview
  52. 7.9.3 FATRO Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 FATRO Duck Medicine and Vaccines Product Portfolio
  54. 7.9.5 FATRO Recent Developments
  55. 7.10 Elanco (Lohmann)
  56. 7.10.1 Elanco (Lohmann) Company Information
  57. 7.10.2 Elanco (Lohmann) Business Overview
  58. 7.10.3 Elanco (Lohmann) Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Elanco (Lohmann) Duck Medicine and Vaccines Product Portfolio
  60. 7.10.5 Elanco (Lohmann) Recent Developments
  61. 7.11 DHN
  62. 7.11.1 DHN Company Information
  63. 7.11.2 DHN Business Overview
  64. 7.11.3 DHN Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 DHN Duck Medicine and Vaccines Product Portfolio
  66. 7.11.5 DHN Recent Developments
  67. 7.12 ChengDu Tecbond
  68. 7.12.1 ChengDu Tecbond Company Information
  69. 7.12.2 ChengDu Tecbond Business Overview
  70. 7.12.3 ChengDu Tecbond Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 ChengDu Tecbond Duck Medicine and Vaccines Product Portfolio
  72. 7.12.5 ChengDu Tecbond Recent Developments
  73. 7.13 CEVA
  74. 7.13.1 CEVA Company Information
  75. 7.13.2 CEVA Business Overview
  76. 7.13.3 CEVA Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CEVA Duck Medicine and Vaccines Product Portfolio
  78. 7.13.5 CEVA Recent Developments
  79. 7.14 CAVAC
  80. 7.14.1 CAVAC Company Information
  81. 7.14.2 CAVAC Business Overview
  82. 7.14.3 CAVAC Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CAVAC Duck Medicine and Vaccines Product Portfolio
  84. 7.14.5 CAVAC Recent Developments
8 North America
  1. 8.1 North America Duck Medicine and Vaccines Revenue (2021-2032)
  2. 8.2 North America Duck Medicine and Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Duck Medicine and Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Duck Medicine and Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Duck Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Duck Medicine and Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Duck Medicine and Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Duck Medicine and Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Duck Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Duck Medicine and Vaccines Revenue by Country
  11. 8.6.1 North America Duck Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Duck Medicine and Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Duck Medicine and Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Duck Medicine and Vaccines Revenue (2021-2032)
  2. 9.2 Europe Duck Medicine and Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Duck Medicine and Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Duck Medicine and Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Duck Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Duck Medicine and Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Duck Medicine and Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Duck Medicine and Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Duck Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Duck Medicine and Vaccines Revenue by Country
  11. 9.6.1 Europe Duck Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Duck Medicine and Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Duck Medicine and Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Duck Medicine and Vaccines Revenue (2021-2032)
  2. 10.2 China Duck Medicine and Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Duck Medicine and Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Duck Medicine and Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Duck Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Duck Medicine and Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Duck Medicine and Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Duck Medicine and Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Duck Medicine and Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Duck Medicine and Vaccines Revenue (2021-2032)
  2. 11.2 Asia Duck Medicine and Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Duck Medicine and Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Duck Medicine and Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Duck Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Duck Medicine and Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Duck Medicine and Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Duck Medicine and Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Duck Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Duck Medicine and Vaccines Revenue by Country
  11. 11.6.1 Asia Duck Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Duck Medicine and Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Duck Medicine and Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Duck Medicine and Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Duck Medicine and Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Duck Medicine and Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Duck Medicine and Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Duck Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Duck Medicine and Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Duck Medicine and Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Duck Medicine and Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Duck Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Duck Medicine and Vaccines Revenue by Country
  11. 12.6.1 SAMEA Duck Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Duck Medicine and Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Duck Medicine and Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst